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Summary In breast cancer patients, pulmonary nodules are frequently considered ametastatic
disease or primary lung tumor. We report the case of a 53-year-old woman with early-stage breast
cancer (T1micN0M0) presenting with asymptomatic pulmonary nodules in the left upper lobe at
follow-up 6 years after she underwent a mastectomy. A presumptive diagnosis of pulmonary
metastasis was made, and the patient underwent a video-assisted thoracoscopic lung biopsy.
Pathology showed granulomatous inflammation with Cryptococcus infection. Subsequently,
antifungal therapy was prescribed, and full recovery followed. We demonstrate the importance
of differentiating between pulmonary Cryptococcus infection and metastasis in breast cancer
patients for correct management. The relationship between pulmonary Cryptococcus infection
and breast cancer is also discussed.
# 2009 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.Introduction
Pulmonary nodules in patients with breast cancer can be
diagnosed as a variant disease. If the patient presents with a
solitary pulmonary nodule, primary lung tumor is the most
common diagnosis.1—4 In contrast, multiple nodules are con-* Corresponding author. Tel.: +886 2 8792 7191;
fax: +886 2 8792 7372.
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doi:10.1016/j.ijid.2009.03.007sidered metastatic lesions rather than a primary lung
tumor.3,4 However, breast cancer patients with pulmonary
nodules presenting with an inflammatory reaction and infec-
tion are uncommon.
Pulmonary cryptococcosis is a rare infection and may be
lethal in an immunocompromised patient. It is important for
clinicians to differentiate between pulmonary cryptococcosis
and malignant pulmonary nodules in breast cancer patients.
We describe a rare case of asymptomatic pulmonary crypto-
coccosis in an early-stage breast cancer patient. Correct
diagnosis and treatment resulted in a favorable outcome.Published by Elsevier Ltd. All rights reserved.
Figure 1 A Chest radiography showing several nodular opacities (black arrow) in the periphery of the left upper lung. (B) Computed
tomography of the chest showing multiple partially ill-defined, soft-tissue nodules (white arrow) in the peripheral region of the left
upper lung.
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A 53-year-old woman with left-sided breast cancer had
undergone a modified radical mastectomy with immediate
breast reconstruction 6 years ago. Pathological examination
had revealed intraductal carcinoma with microinvasion, and
the oncology work-up revealed T1micN0M0, grade II, stage I
disease. The tumor expressed estrogen and progesterone
receptors without HER-2/neu overexpression. Following sur-
gery, the patient received only hormone therapy with tamox-
ifen for 5 years. There was no recurrence or metastasis of
breast carcinoma at follow-up for 5 years. During follow-up at
6 years, chest radiography (Figure 1A) revealed multiple
nodular opacities in the peripheral region of the left lung.
The patient had no associated symptoms such as fever,
productive cough, or chest pain. Laboratory investigations
revealed a white blood cell count of 4.1  109/l, with 51.9%
segmented neutrophils. The levels of the tumor markers
CEA and CA153 were within normal limits. Ultrasonography
of the breast and mammography revealed no evidence ofFigure 2 A Many yeast-form fungi with capsules (arrow) were iden
400). (B) Encapsulated forms of Cryptococcus (arrow) were demorecurrence. Computed tomography (CT) of the chest
(Figure 1B) revealed multiple partially well-defined, soft-
tissue nodules in the peripheral region of the left upper lung;
the largest was 1.2  0.6 cm in size.
In our breast cancer patient with multiple pulmonary
nodules, the possibility of pulmonary metastasis was consid-
ered. Subsequently, she underwent a video-assisted thoraco-
scopic lung biopsy. The pathology (Figure 2A) revealed a
chronic granulomatous inflammatory lesion consistent with
many yeast-form fungi encapsulated within epithelioid cells.
Special staining with mucicarmine confirmed Cryptococcus
infection (Figure 2B). Later, the serology test for Cryptococ-
cus antigen was found to be positive, with a titer of 1:32; no
HIV antibodies were detected. We did not examine the
cerebrospinal fluid because of the low titer of the Crypto-
coccus antigen and the absence of symptoms of central
nervous system (CNS) infection. The patient received anti-
fungal therapy with fluconazole for 3 months. Two months
after the treatment, the serum Cryptococcus antigen titer
decreased to 1:8. No additional respiratory symptoms devel-tified within the epithelioid cells (hematoxylin and eosin stain,
nstrated by mucicarmine stain (400).
Pulmonary cryptococcosis in a breast cancer patient e79oped, and the patient’s chest radiograph returned to normal,
except for several tiny surgical scars that could be observed
on the radiograph.
Discussion
Differentiating between a benign lesion and primary tumor or
metastasis in patients with pulmonary nodules is crucial for
clinicians and is difficult in some patients such as cancer
patients. Surgical resection is the only recommended treat-
ment for early-stage non-small cell lung cancer. Breast can-
cer patients with multiple pulmonary nodules may be
regarded as having metastatic disease and may be treated
immediately with chemotherapy. However, according to the
literature, 5—18% of breast cancer patients with multiple
pulmonary nodules have been found to have non-malignant
disease according to the results of tissue biopsy.1,2,4,5 Thus, it
is important that a biopsy be performed for definite diagnosis
and correct management.
Cryptococcus infection is an opportunistic infection that
predominantly affects immunocompromised patients. HIV
infection is a well-documented major risk factor for Crypto-
coccus infection.6 Idiopathic CD4 lymphocytopenia (ICL) is
characterized by CD4 T-cell depletion in the absence of HIV
infection, and a few cases with Cryptococcus infection have
been reported in recent years. Unlike HIV infection, the
decline in the CD4 cell counts of patients with ICL is often
slow. The clinical presentation of ICL ranges from an asympto-
matic laboratoryabnormality to life-threateningopportunistic
infection.7
In fact, it seems that a large proportion of the population
has been exposed to this fungus, and the subsequent course
of infection is mainly determined by the immune status of
the individual.8 In immunocompromised patients, disease
progression is often rapid and severe. Our patient only
received hormone therapy with tamoxifen for 5 years after
surgery. She exhibited mild leukopenia, and this may have
weakened the defense mechanism against Cryptococcus
infection. Leukopenia has been reported during tamoxifen
therapy but is uncommon, and the white cell count will
return to the normal range in most patients within a few
weeks of stopping treatment.8,9
Approximately one-third of immunocompetent patients
with Cryptococcus infection are asymptomatic, and the most
common symptoms are cough, dyspnea, and fever.10,11 In
asymptomatic patients, the pulmonary infection is usually
discovered incidentally following chest radiography. Infiltra-
tion lesions, partial or well-defined margins, and non-calci-
fied nodules or masses are common, while cavity-like lesions
are less frequently observed but more commonly seen on the
chest radiograph of immunocompromised patients.12,13 Cryp-
tococcus infection of the CNS is dramatically higher in immu-
nocompromised patients. It is a critical to note that at the
time of diagnosis of pulmonary cryptococcal infection, 90% of
HIV/AIDS patients can already have CNS cryptococcosis.11
However, in immunocompetent patients with pulmonary
Cryptococcus infection, subsequent dissemination to the
CNS is infrequent after appropriate treatment.12 Lumbar
puncture is not always necessary for an immunocompetent
patient with pulmonary cryptococcosis; the exception is
patients whose clinical condition worsens, those who present
with the neurologic signs of disease progression, or those witha high serum Cryptococcus antigen titer (>1:250) in the
initial work-up. None of these findings was observed in our
patient, hence lumbar puncture was not performed. Further-
more, the high titer of serum Cryptococcus antigen is a
characteristic of Cryptococcus infection in immunocompro-
mised patients.14
A non-malignant diagnosis in breast cancer patients with
pulmonary nodules is uncommon, and the differential diag-
noses should include histoplasmosis, tuberculosis, cryptococ-
cosis, and harmatoma. However, Cryptococcus infection is
rare in this patient group. Once pulmonary cryptococcosis is
confirmed, the patient should be treated promptly with
antifungal therapy. The majority of patients respond well
to this treatment.
Kontoyiannis et al. studied 31 cancer patients with crypto-
coccosis, including 19 with pulmonary cryptococcosis, and
none of them had been correctly diagnosed before tissue
biopsy or serum culture.15 Therefore, multiple pulmonary
nodules in breast cancer patients may not always be lung
metastases, such as in our case. Only clinical image evaluation
and occasionally pathologic diagnosis can help clinicians diag-
nose correctly so that appropriate treatment is administered.
In patients with early-stage breast cancer, as in our case,
image examinations, including CT scans, may show a suspi-
cious inflammatory process or metastatic lesions. Breast
surgeons face the choice of further chemotherapy or alter-
natives. We suggest that such patients undergo video-
assisted thoracoscopic surgery for tissue diagnosis since this
procedure is safe and not invasive. It can take out more tissue
than CT-guided aspiration cytology, to make a more accurate
diagnosis.
In conclusion, we present the case of a breast cancer
patient with multiple pulmonary nodules who underwent
video-assisted thoracoscopic surgery with lung biopsy to
confirm the diagnosis of Cryptococcus infection. Differentiat-
ing between pulmonary Cryptococcus infection and metas-
tasis in breast cancer patients is important for correct
management.
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